Oral moxifloxacin

DRUG3 trials

Sponsors

Alexza Pharmaceuticals, Inc., Galera Therapeutics, Inc.

Conditions

CardiotoxicityHealthyHealthy VolunteersThorough QT/QTc Study

Phase 1

Staccato Prochlorperazine Thorough QT/QTc

CompletedNCT00543062

Alexza Pharmaceuticals, Inc.Cardiotoxicity

Start: 2007-10-31End: 2007-12-31Updated: 2019-03-11

Staccato Loxapine Thorough QT/QTc Study

CompletedNCT00874237

Alexza Pharmaceuticals, Inc.Thorough QT/QTc Study

Start: 2009-04-30End: 2009-06-30Updated: 2019-10-30

A Phase 1, Randomized, Placebo-and Positive-Controlled Crossover Study to Determine the Effect of Single-Dose GC4419 on QTc Interval in Healthy Volunteers

CompletedNCT03164109

Galera Therapeutics, Inc.Healthy, Healthy Volunteers

Start: 2017-08-18End: 2017-10-13Updated: 2017-11-17